Patents by Inventor Andrew Luster

Andrew Luster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Coversin for Use in the Treatment of Rheumatic Diseases
    Publication number: 20220047673
    Abstract: The present invention relates to methods of treating or preventing rheumatic disease.
    Type: Application
    Filed: September 10, 2019
    Publication date: February 17, 2022
    Applicants: Volution Immuno Pharmaceuticals SA, The General Hospital Corporation
    Inventors: Miles Nunn, Andrew Luster, Yoshishige Miyabe
  • Purposeful movement of human migratory cells away from an agent source
    Publication number: 20070026007
    Abstract: This invention relates to methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention relates to methods and compositions for modulating movement of cells of hematopoietic, neural, epithelial, or mesenchymal origin, in a specific site in a subject. The foregoing are useful, inter alia, in the treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific. sites in a subject. More specifically, specific sites include sites of inflammation and modulation of migratory-cell movement is movement away from an agent source, or repulsion. Other sites include tumor sites, sites of pathogenic infection, and germ cell bearing sites.
    Type: Application
    Filed: April 20, 2006
    Publication date: February 1, 2007
    Inventors: Mark Poznansky, Andrew Luster, David Scadden
  • Use of the cytokine IP-10 as an anti-tumor agent
    Patent number: 6153600
    Abstract: Methods and therapeutic compositions for inhibiting neoplasms by administration of a nucleic acid sequence encoding the IP-10 polypeptide.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: November 28, 2000
    Assignee: President & Fellows of Harvard College
    Inventors: Philip Leder, Andrew Luster
  • Cytokine IP-10 as an anti-tumor agent
    Patent number: 5935567
    Abstract: Methods and therapeutic compositions for treating neoplasms by administration of the polypeptide IP-10, or a suitable DNA vector encoding the polypeptide IP-10.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: August 10, 1999
    Assignee: President and Fellows of Harvard College
    Inventors: Philip Leder, Andrew Luster
  • Modulation of endothelial cell proliferation with IP-10
    Patent number: 5824299
    Abstract: Disclosed are methods for modulating endothelial cell proliferation. Also, disclosed are methods of detecting compounds which inhibit IP-10 and PF4 binding to a HSPG receptor.
    Type: Grant
    Filed: June 22, 1995
    Date of Patent: October 20, 1998
    Assignee: President & Fellows of Harvard College
    Inventors: Andrew Luster, Philip Leder
  • Use of the cytokine IP-10 as an anti-tumor agent
    Patent number: 5474981
    Abstract: Methods and therapeutic compositions for treating neoplasms by administration of the polypeptide IP-10, or a suitable DNA vector encoding the polypeptide IP-10.
    Type: Grant
    Filed: March 23, 1994
    Date of Patent: December 12, 1995
    Assignee: President and Fellows of Harvard College
    Inventors: Philip Leder, Andrew Luster